Literature DB >> 28974571

Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension.

Janice M Diaz-Otero1, Courtney Fisher2, Kelsey Downs2, M Elizabeth Moss2, Iris Z Jaffe2, William F Jackson2, Anne M Dorrance2.   

Abstract

The brain is highly susceptible to injury caused by hypertension because the increased blood pressure causes artery remodeling that can limit cerebral perfusion. Mineralocorticoid receptor (MR) antagonism prevents hypertensive cerebral artery remodeling, but the vascular cell types involved have not been defined. In the periphery, the endothelial MR mediates hypertension-induced vascular injury, but cerebral and peripheral arteries are anatomically distinct; thus, these findings cannot be extrapolated to the brain. The parenchymal arterioles determine cerebrovascular resistance. Determining the effects of hypertension and MR signaling on these arterioles could lead to a better understanding of cerebral small vessel disease. We hypothesized that endothelial MR signaling mediates inward cerebral artery remodeling and reduced cerebral perfusion during angiotensin II (AngII) hypertension. The biomechanics of the parenchymal arterioles and posterior cerebral arteries were studied in male C57Bl/6 and endothelial cell-specific MR knockout mice and their appropriate controls using pressure myography. AngII increased plasma aldosterone and decreased cerebral perfusion in C57Bl/6 and MR-intact littermates. Endothelial cell MR deletion improved cerebral perfusion in AngII-treated mice. AngII hypertension resulted in inward hypotrophic remodeling; this was prevented by MR antagonism and endothelial MR deletion. Our studies suggest that endothelial cell MR mediates hypertensive remodeling in the cerebral microcirculation and large pial arteries. AngII-induced inward remodeling of cerebral arteries and arterioles was associated with a reduction in cerebral perfusion that could worsen the outcome of stroke or contribute to vascular dementia.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  endothelium; hypertension; mice; microcirculation; stroke

Mesh:

Substances:

Year:  2017        PMID: 28974571      PMCID: PMC5680120          DOI: 10.1161/HYPERTENSIONAHA.117.09598

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  45 in total

1.  Central Arterial Aging and Angiotensin II Signaling.

Authors:  Mingyi Wang; Benjamin Khazan; Edward G Lakatta
Journal:  Curr Hypertens Rev       Date:  2010-11-01

2.  Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.

Authors:  Christine' S Rigsby; David M Pollock; Anne M Dorrance
Journal:  Microvasc Res       Date:  2007-01-23       Impact factor: 3.514

3.  Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease.

Authors:  Ciro Ramos-Estebanez; Ignacio Moral-Arce; Andres Gonzalez-Mandly; Vinoop Dhagubatti; Jesus Gonzalez-Macias; Roberto Munoz; Jose Luis Hernadez-Hernandez
Journal:  Age Ageing       Date:  2011-01-14       Impact factor: 10.668

Review 4.  Small artery structure and hypertension: adaptive changes and target organ damage.

Authors:  Ashley S Izzard; Damiano Rizzoni; Enrico Agabiti-Rosei; Anthony M Heagerty
Journal:  J Hypertens       Date:  2005-02       Impact factor: 4.844

Review 5.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

6.  Roles of matrix metalloproteinases in flow-induced outward vascular remodeling.

Authors:  Ryo Ota; Chie Kurihara; Tsung-Ling Tsou; William L Young; Yerem Yeghiazarians; Mayland Chang; Shahriar Mobashery; Atsuhiro Sakamoto; Tomoki Hashimoto
Journal:  J Cereb Blood Flow Metab       Date:  2009-06-10       Impact factor: 6.200

7.  Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta.

Authors:  Jean Marie Ruddy; Jeffrey A Jones; Robert E Stroud; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

8.  TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

Authors:  Siva S V P Sakamuri; Anthony J Valente; Jalahalli M Siddesha; Patrice Delafontaine; Ulrich Siebenlist; Jason D Gardner; Chandrasekar Bysani
Journal:  Mol Cell Endocrinol       Date:  2016-04-01       Impact factor: 4.102

9.  Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress.

Authors:  Quynh Nhu Dinh; Grant R Drummond; Barbara K Kemp-Harper; Henry Diep; T Michael De Silva; Hyun Ah Kim; Antony Vinh; Avril A B Robertson; Matthew A Cooper; Ashley Mansell; Sophocles Chrissobolis; Christopher G Sobey
Journal:  Aging (Albany NY)       Date:  2017-06-28       Impact factor: 5.682

10.  Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.

Authors:  Ane M Salvador; M Elizabeth Moss; Mark Aronovitz; Kathleen B Mueller; Robert M Blanton; Iris Z Jaffe; Pilar Alcaide
Journal:  Physiol Rep       Date:  2017-06
View more
  15 in total

1.  LIMK (LIM Kinase) Inhibition Prevents Vasoconstriction- and Hypertension-Induced Arterial Stiffening and Remodeling.

Authors:  Mariana Morales-Quinones; Francisco I Ramirez-Perez; Christopher A Foote; Thaysa Ghiarone; Larissa Ferreira-Santos; Maria Bloksgaard; Nicole Spencer; Eric T Kimchi; Camila Manrique-Acevedo; Jaume Padilla; Luis A Martinez-Lemus
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

2.  Augmented astrocyte microdomain Ca2+ dynamics and parenchymal arteriole tone in angiotensin II-infused hypertensive mice.

Authors:  Juan Ramiro Diaz; Ki Jung Kim; Michael W Brands; Jessica A Filosa
Journal:  Glia       Date:  2018-12-02       Impact factor: 7.452

Review 3.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

4.  Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.

Authors:  Janice M Diaz-Otero; Ting-Chieh Yen; Courtney Fisher; Daniel Bota; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

Review 5.  Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.

Authors:  Gregory L Hundemer
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 6.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

7.  Transient receptor potential vanilloid 4 channels are important regulators of parenchymal arteriole dilation and cognitive function.

Authors:  Janice M Diaz-Otero; Ting-Chieh Yen; Amna Ahmad; Erinn Laimon-Thomson; Bana Abolibdeh; Kara Kelly; Matthew T Lewis; Robert W Wiseman; William F Jackson; Anne M Dorrance
Journal:  Microcirculation       Date:  2019-02-22       Impact factor: 2.628

8.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

Review 9.  Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle.

Authors:  Lauren A Biwer; Mary C Wallingford; Iris Z Jaffe
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

Review 10.  Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.